1928Diagnostics

Project introduction

Our products analyzes raw data from genome sequencing machines and matches the processed data to the proprietary databases that have been manually curated containing only clinical relevant genetic markers. The result in the form of a resistance and typing

SHARE:
  • Initiator:
  • Code:
  • Type: Equity transfer
  • Amount:
  • Highlights: By being a front-runner in the technical development of personalized medicine, we have an unique position of addressing the global challenge of antibiotic resistance.

Register to get details of the project

Related roadshow